 |
|
|
|
|
FDA Steps Up Oversight of Body Parts Companies
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 | 3 New York Sen. Charles Schumer, who has a bill pending to regulate the tissue industry, called the new report a good first step but more needs to be done.
"Recent tissue scandals highlight a new problem that is not only profoundly troubling, but also threatens the health of the very individuals who believe they are receiving life-saving treatments," Schumer, a Democrat, said in a prepared statement. "More inspections are certainly needed but we hope that the FDA will also consider an accreditation system for tissue banks, strict information standards and tougher penalties for violators. All four are needed to plug gaping holes in the tissue transplant industry."
More information
Text Continues Below
For more on tissue for transplants, visit the U.S. Food and Drug Administration.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 6/12/2007
|
|
SOURCES: June 12, 2007, teleconference with Celia Witten, M.D., Ph.D., director, Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration; David Elder, director, Office of Enforcement, Office of Regulatory Affairs, U.S. Food and Drug Administration; Associated Press; June 12, 2007, prepared statement, Sen. Charles Schumer, D-N.Y.
|
.gif)
